AU3788899A - Genomic sequences upstream of the coding region of the ifn-alpha2 gene for protein production and delivery - Google Patents

Genomic sequences upstream of the coding region of the ifn-alpha2 gene for protein production and delivery Download PDF

Info

Publication number: AU3788899A
Authority: AU; Australia
Prior art keywords: cell; ifna2; seq; nucleic acid; isolated nucleic
Prior art date: 1998-05-07
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Abandoned

Application number

AU37888/99A

Other languages

English (en)

Inventor

Michael W Heartlein

Richard F. Selden

Douglas A. Treco

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Shire Human Genetics Therapies Inc

Original Assignee

Transkaryotic Therapies Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1998-05-07

Filing date

1999-05-05

Publication date

1999-11-23

1999-05-05 Application filed by Transkaryotic Therapies Inc filed Critical Transkaryotic Therapies Inc

1999-11-23 Publication of AU3788899A publication Critical patent/AU3788899A/en

Status Abandoned legal-status Critical Current

Links

108090000623 proteins and genes Proteins 0.000 title claims description 69
108091026890 Coding region Proteins 0.000 title claims description 38
238000011144 upstream manufacturing Methods 0.000 title claims description 32
230000014616 translation Effects 0.000 title description 6
210000004027 cell Anatomy 0.000 claims description 197
108020004414 DNA Proteins 0.000 claims description 89
239000002773 nucleotide Substances 0.000 claims description 72
125000003729 nucleotide group Chemical group 0.000 claims description 72
230000008685 targeting Effects 0.000 claims description 72
101000959794 Homo sapiens Interferon alpha-2 Proteins 0.000 claims description 71
102100040018 Interferon alpha-2 Human genes 0.000 claims description 68
108020005067 RNA Splice Sites Proteins 0.000 claims description 68
230000001105 regulatory effect Effects 0.000 claims description 51
238000002744 homologous recombination Methods 0.000 claims description 39
230000006801 homologous recombination Effects 0.000 claims description 39
101150043201 IFNA2 gene Proteins 0.000 claims description 37
239000003550 marker Substances 0.000 claims description 37
108020004707 nucleic acids Proteins 0.000 claims description 36
102000039446 nucleic acids Human genes 0.000 claims description 36
150000007523 nucleic acids Chemical class 0.000 claims description 36
238000000034 method Methods 0.000 claims description 35
230000014509 gene expression Effects 0.000 claims description 28
230000000295 complement effect Effects 0.000 claims description 25
239000012634 fragment Substances 0.000 claims description 19
241001465754 Metazoa Species 0.000 claims description 16
238000000338 in vitro Methods 0.000 claims description 15
108091081024 Start codon Proteins 0.000 claims description 12
210000004962 mammalian cell Anatomy 0.000 claims description 11
230000010354 integration Effects 0.000 claims description 8
230000002103 transcriptional effect Effects 0.000 claims description 8
238000012258 culturing Methods 0.000 claims description 7
230000006798 recombination Effects 0.000 claims description 5
238000005215 recombination Methods 0.000 claims description 5
102000004169 proteins and genes Human genes 0.000 description 19
239000013612 plasmid Substances 0.000 description 16
238000001415 gene therapy Methods 0.000 description 12
239000013615 primer Substances 0.000 description 12
241000700605 Viruses Species 0.000 description 9
238000003752 polymerase chain reaction Methods 0.000 description 9
208000015181 infectious disease Diseases 0.000 description 8
238000004519 manufacturing process Methods 0.000 description 8
239000000523 sample Substances 0.000 description 8
230000004888 barrier function Effects 0.000 description 7
239000000463 material Substances 0.000 description 7
239000013603 viral vector Substances 0.000 description 7
108091032973 (ribonucleotides)n+m Proteins 0.000 description 6
230000035772 mutation Effects 0.000 description 6
241000894007 species Species 0.000 description 6
210000001519 tissue Anatomy 0.000 description 6
238000001890 transfection Methods 0.000 description 6
108700026220 vif Genes Proteins 0.000 description 6
108020004705 Codon Proteins 0.000 description 5
102000008186 Collagen Human genes 0.000 description 5
108010035532 Collagen Proteins 0.000 description 5
108091028043 Nucleic acid sequence Proteins 0.000 description 5
229920001436 collagen Polymers 0.000 description 5
229920001184 polypeptide Polymers 0.000 description 5
108090000765 processed proteins & peptides Proteins 0.000 description 5
102000004196 processed proteins & peptides Human genes 0.000 description 5
230000001225 therapeutic effect Effects 0.000 description 5
238000013518 transcription Methods 0.000 description 5
230000035897 transcription Effects 0.000 description 5
101100396576 Gallus gallus IFNB gene Proteins 0.000 description 4
101100125742 Homo sapiens IFNA2 gene Proteins 0.000 description 4
108010076504 Protein Sorting Signals Proteins 0.000 description 4
210000000349 chromosome Anatomy 0.000 description 4
210000005260 human cell Anatomy 0.000 description 4
238000009396 hybridization Methods 0.000 description 4
230000001404 mediated effect Effects 0.000 description 4
239000002243 precursor Substances 0.000 description 4
239000000047 product Substances 0.000 description 4
238000012216 screening Methods 0.000 description 4
230000028327 secretion Effects 0.000 description 4
108091029865 Exogenous DNA Proteins 0.000 description 3
241000251539 Vertebrata <Metazoa> Species 0.000 description 3
230000004075 alteration Effects 0.000 description 3
239000003795 chemical substances by application Substances 0.000 description 3
210000002919 epithelial cell Anatomy 0.000 description 3
210000002950 fibroblast Anatomy 0.000 description 3
230000012010 growth Effects 0.000 description 3
102000051099 human IFNA2 Human genes 0.000 description 3
238000002513 implantation Methods 0.000 description 3
238000001727 in vivo Methods 0.000 description 3
239000000203 mixture Substances 0.000 description 3
230000014621 translational initiation Effects 0.000 description 3
241001430294 unidentified retrovirus Species 0.000 description 3
230000003612 virological effect Effects 0.000 description 3
241000283690 Bos taurus Species 0.000 description 2
241000283707 Capra Species 0.000 description 2
241000700199 Cavia porcellus Species 0.000 description 2
241000699800 Cricetinae Species 0.000 description 2
241000701022 Cytomegalovirus Species 0.000 description 2
239000003155 DNA primer Substances 0.000 description 2
229920002307 Dextran Polymers 0.000 description 2
238000002965 ELISA Methods 0.000 description 2
241000709661 Enterovirus Species 0.000 description 2
241000283073 Equus caballus Species 0.000 description 2
241000282326 Felis catus Species 0.000 description 2
ZHNUHDYFZUAESO-UHFFFAOYSA-N Formamide Chemical compound NC=O ZHNUHDYFZUAESO-UHFFFAOYSA-N 0.000 description 2
208000005176 Hepatitis C Diseases 0.000 description 2
208000007514 Herpes zoster Diseases 0.000 description 2
108020005350 Initiator Codon Proteins 0.000 description 2
102100034343 Integrase Human genes 0.000 description 2
108010061833 Integrases Proteins 0.000 description 2
108091092195 Intron Proteins 0.000 description 2
241000699666 Mus <mouse, genus> Species 0.000 description 2
229930193140 Neomycin Natural products 0.000 description 2
241000283973 Oryctolagus cuniculus Species 0.000 description 2
241001631646 Papillomaviridae Species 0.000 description 2
241001494479 Pecora Species 0.000 description 2
241000009328 Perro Species 0.000 description 2
241000700159 Rattus Species 0.000 description 2
239000006146 Roswell Park Memorial Institute medium Substances 0.000 description 2
241000700584 Simplexvirus Species 0.000 description 2
241000282898 Sus scrofa Species 0.000 description 2
108700009124 Transcription Initiation Site Proteins 0.000 description 2
108091023040 Transcription factor Proteins 0.000 description 2
102000040945 Transcription factor Human genes 0.000 description 2
206010046865 Vaccinia virus infection Diseases 0.000 description 2
230000002159 abnormal effect Effects 0.000 description 2
230000000735 allogeneic effect Effects 0.000 description 2
125000003275 alpha amino acid group Chemical group 0.000 description 2
230000001580 bacterial effect Effects 0.000 description 2
230000008901 benefit Effects 0.000 description 2
230000033228 biological regulation Effects 0.000 description 2
239000001506 calcium phosphate Substances 0.000 description 2
229910000389 calcium phosphate Inorganic materials 0.000 description 2
235000011010 calcium phosphates Nutrition 0.000 description 2
230000001413 cellular effect Effects 0.000 description 2
230000002759 chromosomal effect Effects 0.000 description 2
238000012217 deletion Methods 0.000 description 2
230000037430 deletion Effects 0.000 description 2
238000010586 diagram Methods 0.000 description 2
238000004520 electroporation Methods 0.000 description 2
208000002672 hepatitis B Diseases 0.000 description 2
230000001965 increasing effect Effects 0.000 description 2
230000000977 initiatory effect Effects 0.000 description 2
210000000265 leukocyte Anatomy 0.000 description 2
239000011159 matrix material Substances 0.000 description 2
239000002609 medium Substances 0.000 description 2
108020004999 messenger RNA Proteins 0.000 description 2
238000000520 microinjection Methods 0.000 description 2
229960004927 neomycin Drugs 0.000 description 2
229920000642 polymer Polymers 0.000 description 2
229920000915 polyvinyl chloride Polymers 0.000 description 2
239000004800 polyvinyl chloride Substances 0.000 description 2
230000010076 replication Effects 0.000 description 2
238000011160 research Methods 0.000 description 2
108091008146 restriction endonucleases Proteins 0.000 description 2
239000000126 substance Substances 0.000 description 2
239000000758 substrate Substances 0.000 description 2
238000002560 therapeutic procedure Methods 0.000 description 2
238000011282 treatment Methods 0.000 description 2
QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 2
241000701161 unidentified adenovirus Species 0.000 description 2
208000007089 vaccinia Diseases 0.000 description 2
239000013598 vector Substances 0.000 description 2
-1 y-actin) Proteins 0.000 description 2
BFSVOASYOCHEOV-UHFFFAOYSA-N 2-diethylaminoethanol Chemical compound CCN(CC)CCO BFSVOASYOCHEOV-UHFFFAOYSA-N 0.000 description 1
101150055869 25 gene Proteins 0.000 description 1
102000007469 Actins Human genes 0.000 description 1
108010085238 Actins Proteins 0.000 description 1
108700028369 Alleles Proteins 0.000 description 1
241000894006 Bacteria Species 0.000 description 1
108091003079 Bovine Serum Albumin Proteins 0.000 description 1
206010006187 Breast cancer Diseases 0.000 description 1
208000026310 Breast neoplasm Diseases 0.000 description 1
UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 1
241000178270 Canarypox virus Species 0.000 description 1
201000009030 Carcinoma Diseases 0.000 description 1
108020004638 Circular DNA Proteins 0.000 description 1
108060005980 Collagenase Proteins 0.000 description 1
102000029816 Collagenase Human genes 0.000 description 1
108091035707 Consensus sequence Proteins 0.000 description 1
102000053602 DNA Human genes 0.000 description 1
241000702421 Dependoparvovirus Species 0.000 description 1
KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
238000008157 ELISA kit Methods 0.000 description 1
241000991587 Enterovirus C Species 0.000 description 1
241000701959 Escherichia virus Lambda Species 0.000 description 1
108700024394 Exon Proteins 0.000 description 1
108060002716 Exonuclease Proteins 0.000 description 1
102000016359 Fibronectins Human genes 0.000 description 1
108010067306 Fibronectins Proteins 0.000 description 1
241000282412 Homo Species 0.000 description 1
101000599940 Homo sapiens Interferon gamma Proteins 0.000 description 1
108090000895 Hydroxymethylglutaryl CoA Reductases Proteins 0.000 description 1
102000004286 Hydroxymethylglutaryl CoA Reductases Human genes 0.000 description 1
108060003951 Immunoglobulin Proteins 0.000 description 1
102100037850 Interferon gamma Human genes 0.000 description 1
241000713666 Lentivirus Species 0.000 description 1
108700018351 Major Histocompatibility Complex Proteins 0.000 description 1
241000124008 Mammalia Species 0.000 description 1
102000000422 Matrix Metalloproteinase 3 Human genes 0.000 description 1
102000005741 Metalloproteases Human genes 0.000 description 1
108010006035 Metalloproteases Proteins 0.000 description 1
241000711386 Mumps virus Species 0.000 description 1
101000969137 Mus musculus Metallothionein-1 Proteins 0.000 description 1
206010028980 Neoplasm Diseases 0.000 description 1
239000000020 Nitrocellulose Substances 0.000 description 1
108091093105 Nuclear DNA Proteins 0.000 description 1
108700026244 Open Reading Frames Proteins 0.000 description 1
206010033128 Ovarian cancer Diseases 0.000 description 1
238000002944 PCR assay Methods 0.000 description 1
102000010752 Plasminogen Inactivators Human genes 0.000 description 1
108010077971 Plasminogen Inactivators Proteins 0.000 description 1
CZPWVGJYEJSRLH-UHFFFAOYSA-N Pyrimidine Chemical compound C1=CN=CN=C1 CZPWVGJYEJSRLH-UHFFFAOYSA-N 0.000 description 1
108010000605 Ribosomal Proteins Proteins 0.000 description 1
102000002278 Ribosomal Proteins Human genes 0.000 description 1
241000710960 Sindbis virus Species 0.000 description 1
108020004682 Single-Stranded DNA Proteins 0.000 description 1
210000001744 T-lymphocyte Anatomy 0.000 description 1
108700026226 TATA Box Proteins 0.000 description 1
108091036066 Three prime untranslated region Proteins 0.000 description 1
108010046075 Thymosin Proteins 0.000 description 1
102000007501 Thymosin Human genes 0.000 description 1
241000700618 Vaccinia virus Species 0.000 description 1
102100035071 Vimentin Human genes 0.000 description 1
108010065472 Vimentin Proteins 0.000 description 1
208000036142 Viral infection Diseases 0.000 description 1
230000003213 activating effect Effects 0.000 description 1
230000004913 activation Effects 0.000 description 1
125000000539 amino acid group Chemical group 0.000 description 1
150000001413 amino acids Chemical class 0.000 description 1
238000004458 analytical method Methods 0.000 description 1
230000000840 anti-viral effect Effects 0.000 description 1
239000000427 antigen Substances 0.000 description 1
108091007433 antigens Proteins 0.000 description 1
102000036639 antigens Human genes 0.000 description 1
238000013459 approach Methods 0.000 description 1
210000001106 artificial yeast chromosome Anatomy 0.000 description 1
230000003190 augmentative effect Effects 0.000 description 1
210000003719 b-lymphocyte Anatomy 0.000 description 1
239000011324 bead Substances 0.000 description 1
230000003115 biocidal effect Effects 0.000 description 1
230000015572 biosynthetic process Effects 0.000 description 1
210000004369 blood Anatomy 0.000 description 1
239000008280 blood Substances 0.000 description 1
210000002798 bone marrow cell Anatomy 0.000 description 1
229940098773 bovine serum albumin Drugs 0.000 description 1
239000001110 calcium chloride Substances 0.000 description 1
229910001628 calcium chloride Inorganic materials 0.000 description 1
201000011510 cancer Diseases 0.000 description 1
239000002775 capsule Substances 0.000 description 1
230000015556 catabolic process Effects 0.000 description 1
239000013592 cell lysate Substances 0.000 description 1
239000006285 cell suspension Substances 0.000 description 1
239000001913 cellulose Substances 0.000 description 1
229920002678 cellulose Polymers 0.000 description 1
229920002301 cellulose acetate Polymers 0.000 description 1
230000008859 change Effects 0.000 description 1
238000006243 chemical reaction Methods 0.000 description 1
150000001805 chlorine compounds Chemical class 0.000 description 1
239000013611 chromosomal DNA Substances 0.000 description 1
238000010367 cloning Methods 0.000 description 1
238000000975 co-precipitation Methods 0.000 description 1
229960002424 collagenase Drugs 0.000 description 1
238000010276 construction Methods 0.000 description 1
239000012228 culture supernatant Substances 0.000 description 1
230000003247 decreasing effect Effects 0.000 description 1
238000006731 degradation reaction Methods 0.000 description 1
230000001419 dependent effect Effects 0.000 description 1
201000010099 disease Diseases 0.000 description 1
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
230000000694 effects Effects 0.000 description 1
238000005538 encapsulation Methods 0.000 description 1
210000002889 endothelial cell Anatomy 0.000 description 1
239000003623 enhancer Substances 0.000 description 1
230000001747 exhibiting effect Effects 0.000 description 1
102000013165 exonuclease Human genes 0.000 description 1
238000001914 filtration Methods 0.000 description 1
230000004927 fusion Effects 0.000 description 1
210000001035 gastrointestinal tract Anatomy 0.000 description 1
238000010363 gene targeting Methods 0.000 description 1
230000002068 genetic effect Effects 0.000 description 1
238000010353 genetic engineering Methods 0.000 description 1
102000006602 glyceraldehyde-3-phosphate dehydrogenase Human genes 0.000 description 1
108020004445 glyceraldehyde-3-phosphate dehydrogenase Proteins 0.000 description 1
210000003917 human chromosome Anatomy 0.000 description 1
210000000987 immune system Anatomy 0.000 description 1
102000018358 immunoglobulin Human genes 0.000 description 1
239000007943 implant Substances 0.000 description 1
230000006872 improvement Effects 0.000 description 1
230000006698 induction Effects 0.000 description 1
230000001939 inductive effect Effects 0.000 description 1
239000003112 inhibitor Substances 0.000 description 1
230000000968 intestinal effect Effects 0.000 description 1
238000007918 intramuscular administration Methods 0.000 description 1
238000007912 intraperitoneal administration Methods 0.000 description 1
238000007913 intrathecal administration Methods 0.000 description 1
238000001990 intravenous administration Methods 0.000 description 1
210000002510 keratinocyte Anatomy 0.000 description 1
210000003734 kidney Anatomy 0.000 description 1
208000032839 leukemia Diseases 0.000 description 1
238000001638 lipofection Methods 0.000 description 1
239000002502 liposome Substances 0.000 description 1
210000004698 lymphocyte Anatomy 0.000 description 1
210000002540 macrophage Anatomy 0.000 description 1
238000012423 maintenance Methods 0.000 description 1
230000007246 mechanism Effects 0.000 description 1
201000001441 melanoma Diseases 0.000 description 1
239000012528 membrane Substances 0.000 description 1
210000004379 membrane Anatomy 0.000 description 1
230000000813 microbial effect Effects 0.000 description 1
244000005700 microbiome Species 0.000 description 1
239000003094 microcapsule Substances 0.000 description 1
238000012986 modification Methods 0.000 description 1
230000004048 modification Effects 0.000 description 1
210000000663 muscle cell Anatomy 0.000 description 1
230000001537 neural effect Effects 0.000 description 1
210000004498 neuroglial cell Anatomy 0.000 description 1
229920001220 nitrocellulos Polymers 0.000 description 1
210000004940 nucleus Anatomy 0.000 description 1
210000002747 omentum Anatomy 0.000 description 1
238000004806 packaging method and process Methods 0.000 description 1
230000037361 pathway Effects 0.000 description 1
230000035699 permeability Effects 0.000 description 1
239000008194 pharmaceutical composition Substances 0.000 description 1
239000013600 plasmid vector Substances 0.000 description 1
239000002797 plasminogen activator inhibitor Substances 0.000 description 1
229920002492 poly(sulfone) Polymers 0.000 description 1
229920002981 polyvinylidene fluoride Polymers 0.000 description 1
238000001556 precipitation Methods 0.000 description 1
238000002360 preparation method Methods 0.000 description 1
230000008569 process Effects 0.000 description 1
230000000644 propagated effect Effects 0.000 description 1
230000002685 pulmonary effect Effects 0.000 description 1
239000002213 purine nucleotide Substances 0.000 description 1
210000003705 ribosome Anatomy 0.000 description 1
238000012163 sequencing technique Methods 0.000 description 1
210000001082 somatic cell Anatomy 0.000 description 1
108091007196 stromelysin Proteins 0.000 description 1
238000007920 subcutaneous administration Methods 0.000 description 1
239000006228 supernatant Substances 0.000 description 1
230000020382 suppression by virus of host antigen processing and presentation of peptide antigen via MHC class I Effects 0.000 description 1
239000000725 suspension Substances 0.000 description 1
238000004114 suspension culture Methods 0.000 description 1
238000003786 synthesis reaction Methods 0.000 description 1
230000001839 systemic circulation Effects 0.000 description 1
238000012360 testing method Methods 0.000 description 1
LCJVIYPJPCBWKS-NXPQJCNCSA-N thymosin Chemical compound SC[C@@H](N)C(=O)N[C@H](CO)C(=O)N[C@H](CC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@H](C(C)C)C(=O)N[C@H](CC(O)=O)C(=O)N[C@H](C(C)C)C(=O)N[C@H](CO)C(=O)N[C@H](CO)C(=O)N[C@H](CCC(O)=O)C(=O)N[C@H]([C@@H](C)CC)C(=O)N[C@H]([C@H](C)O)C(=O)N[C@H](C(C)C)C(=O)N[C@H](CCCCN)C(=O)N[C@H](CC(O)=O)C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N[C@H](CCC(O)=O)C(=O)N[C@H](CCCCN)C(=O)N[C@H](CCCCN)C(=O)N[C@H](CCC(O)=O)C(=O)N[C@H](C(C)C)C(=O)N[C@H](C(C)C)C(=O)N[C@H](CCC(O)=O)C(=O)N[C@H](CCC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@H](CCC(O)=O)C(O)=O LCJVIYPJPCBWKS-NXPQJCNCSA-N 0.000 description 1
230000005026 transcription initiation Effects 0.000 description 1
230000005030 transcription termination Effects 0.000 description 1
230000001052 transient effect Effects 0.000 description 1
238000013519 translation Methods 0.000 description 1
238000011269 treatment regimen Methods 0.000 description 1
241001529453 unidentified herpesvirus Species 0.000 description 1
210000005048 vimentin Anatomy 0.000 description 1
230000009385 viral infection Effects 0.000 description 1
238000005406 washing Methods 0.000 description 1

Classifications

- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
- C07K14/555—Interferons [IFN]
- C07K14/56—IFN-alpha
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/67—General methods for enhancing the expression
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
- C12N15/90—Stable introduction of foreign DNA into chromosome
- C12N15/902—Stable introduction of foreign DNA into chromosome using homologous recombination
- C12N15/907—Stable introduction of foreign DNA into chromosome using homologous recombination in mammalian cells
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2840/00—Vectors comprising a special translation-regulating system
- C12N2840/44—Vectors comprising a special translation-regulating system being a specific part of the splice mechanism, e.g. donor, acceptor

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Genetics & Genomics (AREA)
Chemical & Material Sciences (AREA)
Engineering & Computer Science (AREA)
Organic Chemistry (AREA)
Zoology (AREA)
Wood Science & Technology (AREA)
Biomedical Technology (AREA)
Biotechnology (AREA)
General Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
General Health & Medical Sciences (AREA)
Molecular Biology (AREA)
Biophysics (AREA)
Biochemistry (AREA)
Plant Pathology (AREA)
Physics & Mathematics (AREA)
Microbiology (AREA)
Medicinal Chemistry (AREA)
General Chemical & Material Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Pharmacology & Pharmacy (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Animal Behavior & Ethology (AREA)
Communicable Diseases (AREA)
Cell Biology (AREA)
Oncology (AREA)
Virology (AREA)
Mycology (AREA)
Toxicology (AREA)
Gastroenterology & Hepatology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Peptides Or Proteins (AREA)

AU37888/99A 1998-05-07 1999-05-05 Genomic sequences upstream of the coding region of the ifn-alpha2 gene for protein production and delivery Abandoned AU3788899A (en)

Applications Claiming Priority (5)

Application Number	Priority Date	Filing Date	Title
US8464898P	1998-05-07	1998-05-07
US60084648		1998-05-07
US8655598P	1998-05-21	1998-05-21
US60086555		1998-05-21
PCT/US1999/009925 WO1999057292A1 (en)	1998-05-07	1999-05-05	Genomic sequences upstream of the coding region of the ifn-alpha2 gene for protein production and delivery

Publications (1)

Publication Number	Publication Date
AU3788899A true AU3788899A (en)	1999-11-23

Family

ID=26771248

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AU37888/99A Abandoned AU3788899A (en)	1998-05-07	1999-05-05	Genomic sequences upstream of the coding region of the ifn-alpha2 gene for protein production and delivery

Country Status (14)

Country	Link
EP (1)	EP1075531A1 (cs)
JP (1)	JP2002513580A (cs)
KR (1)	KR20010052278A (cs)
CN (1)	CN1309710A (cs)
AR (1)	AR016264A1 (cs)
AU (1)	AU3788899A (cs)
CA (1)	CA2328459A1 (cs)
CZ (1)	CZ299418B6 (cs)
HU (1)	HUP0102517A3 (cs)
IL (1)	IL139433A0 (cs)
NO (1)	NO20005585L (cs)
PL (1)	PL344517A1 (cs)
TR (1)	TR200003271T2 (cs)
WO (1)	WO1999057292A1 (cs)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO2001042442A2 (en)	1999-12-10	2001-06-14	Cytos Biotechnology Ag	Activation of endogenous genes by genomic introduction of a replicon
FR2817559B1 (fr) *	2000-12-06	2003-12-12	Genodyssee	Procede de determination d'un ou plusieurs polymorphisme(s) fontionnel(s) dans la sequence nucleique d'un gene "candidat" fonctionnel preselectionne et ses applications
WO2012139195A1 (en) *	2011-04-13	2012-10-18	National Research Council Of Canada	EXPRESSION SYSTEM WITH SAR ELEMENT FROM IFNα2

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5641670A (en) *	1991-11-05	1997-06-24	Transkaryotic Therapies, Inc.	Protein production and protein delivery

1999
- 1999-05-05 IL IL13943399A patent/IL139433A0/xx unknown
- 1999-05-05 CZ CZ20003705A patent/CZ299418B6/cs not_active IP Right Cessation
- 1999-05-05 CN CN99808195A patent/CN1309710A/zh active Pending
- 1999-05-05 EP EP99920375A patent/EP1075531A1/en not_active Withdrawn
- 1999-05-05 HU HU0102517A patent/HUP0102517A3/hu unknown
- 1999-05-05 AU AU37888/99A patent/AU3788899A/en not_active Abandoned
- 1999-05-05 WO PCT/US1999/009925 patent/WO1999057292A1/en not_active Ceased
- 1999-05-05 JP JP2000547246A patent/JP2002513580A/ja active Pending
- 1999-05-05 TR TR2000/03271T patent/TR200003271T2/xx unknown
- 1999-05-05 KR KR1020007012066A patent/KR20010052278A/ko not_active Withdrawn
- 1999-05-05 PL PL99344517A patent/PL344517A1/xx not_active Application Discontinuation
- 1999-05-05 CA CA002328459A patent/CA2328459A1/en not_active Abandoned
- 1999-05-06 AR ARP990102133A patent/AR016264A1/es not_active Application Discontinuation
2000
- 2000-11-06 NO NO20005585A patent/NO20005585L/no not_active Application Discontinuation

Also Published As

Publication number	Publication date
HUP0102517A3 (en)	2004-06-28
WO1999057292A9 (en)	1999-12-16
NO20005585D0 (no)	2000-11-06
AR016264A1 (es)	2001-06-20
IL139433A0 (en)	2001-11-25
EP1075531A1 (en)	2001-02-14
CN1309710A (zh)	2001-08-22
NO20005585L (no)	2001-01-05
TR200003271T2 (tr)	2001-03-21
KR20010052278A (ko)	2001-06-25
CZ20003705A3 (cs)	2001-04-11
JP2002513580A (ja)	2002-05-14
WO1999057292A1 (en)	1999-11-11
PL344517A1 (en)	2001-11-05
HUP0102517A2 (hu)	2001-11-28
CZ299418B6 (cs)	2008-07-16
CA2328459A1 (en)	1999-11-11

Legal Events

Date	Code	Title	Description
2004-04-08	MK5	Application lapsed section 142(2)(e) - patent request and compl. specification not accepted

Publication	Publication Date	Title
CA2005016C (en)	2003-03-18	Dna fragment containing promoter region for human polypeptide chain elongation factor-1.alpha. and expression plasmid containing the dna fragment
AU2018315428B2 (en)	2024-11-14	Integration sites in CHO cells
Zeng et al.	1997	Retrovirus-mediated gene transfer corrects DNA repair defect of xeroderma pigmentosum cells of complementation groups A, B and C
WO2001032901A1 (en)	2001-05-10	Expression vectors, transfection systems, and method of use thereof
AU3788799A (en)	1999-11-23	Genomic sequences upstream of the coding region of the g-csf gene for protein production and delivery
Merrill et al.	1984	Genetic and physical analysis of the chicken tk gene
WO1999057263A9 (en)	2000-03-02	Modifying the expression of the fsh beta gene by homologous recombination
CN113544257A (zh)	2021-10-22	中国仓鼠卵巢细胞中内源性逆转录病毒的表征及灭活
US5681942A (en)	1997-10-28	Fanconi Anemia Type C gene
Chan et al.	1993	Mouse α-1-microglobulin/bikunin precursor: cDNA analysis, gene evolution and physical assignment of the gene next to the orosomucoid locus
AU3788899A (en)	1999-11-23	Genomic sequences upstream of the coding region of the ifn-alpha2 gene for protein production and delivery
US5952190A (en)	1999-09-14	cDNA for fanconi anemia complementation group A
EP0369458A2 (en)	1990-05-23	Bovine metallothionein regulatory region